Clinical Trials Browser

Phase 1/2 × gedatolisib × 90 days × Clear all

Genital Diseases, Male, Prostatic Diseases, Prostatic Neoplasms, Male Urogenital Diseases, Prostatic Neoplasms, Castration-Resistant